LNSRLENSAR, Inc.

$142M

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$17M+38.2% YoY

Gross Profit

$7M42.5% margin

Operating Income

-$1M-7.7% margin

Net Income

-$19M-111.8% margin

EPS (Diluted)

$-1.61

QoQ Revenue Growth

+23.6%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$4M

Stock-Based Comp.

$662,000

Balance Sheet

Total Assets

$66M

Total Liabilities

$61M

Stockholders' Equity

$5M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$12M	+38.2%
Gross Profit	$7M	$5M	+45.8%
Operating Income	-$1M	-$3M	+56.4%
Net Income	-$19M	-$4M	-376.4%

Revenue Segments

Product

$23M90%

Service

$2M10%

Geographic Segments

UNITED STATES

$17M66%

Europe

$5M20%

Asia Excluding South Korea

$3M10%

Other Geographical Region

$446,0002%

KOREA, REPUBLIC OF

$425,0002%

LNSR Q4 2024 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena